Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Bicalutamide shows promise for treating female hair loss.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Flutamide, delivered by solid lipid nanoparticles, could potentially treat hair loss.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

RU 58841 may treat acne, hair loss, and excessive hair growth.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.